Literature DB >> 8712637

Role of substance P in the vascular response of nasal mucosa in nasal allergy.

A Konno1, T Numata, N Terada, T Hanazawa, H Nagata, H Motosugi.   

Abstract

The effects of topically administered substance P (SP) on nasal blood flow and nasal airway resistance (NAR) were evaluated in 11 subjects with perennial nasal allergy. The change in NAR induced by SP was compared with those induced by nasal challenge with histamine, leukotriene D4 (LTD4), and antigen. In doses > or = 16 nmol, SP caused a significant increase of nasal blood flow within 5 minutes that lasted for less than 20 minutes. In doses > or = 16 nmol, SP caused a dose-dependent, short-lasting, significant increase in NAR. The magnitude of the increase in NAR was LTD4 > SP > histamine when compared on a molar basis. Our results may suggest that SP released from C fiber terminals is partially involved in an early nasal vascular response after antigen challenge by acting on adjacent vascular smooth muscle to cause a transient vasodilatation of both resistance and capacitance vessels only while sensory stimulation persists in subjects with nasal allergy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8712637     DOI: 10.1177/000348949610500811

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  3 in total

1.  Historical, pathophysiological, and therapeutic aspects of vidian neurectomy.

Authors:  Akiyoshi Konno
Journal:  Curr Allergy Asthma Rep       Date:  2010-03       Impact factor: 4.806

Review 2.  Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis.

Authors:  M Peters-Golden; M M Gleason; A Togias
Journal:  Clin Exp Allergy       Date:  2006-06       Impact factor: 5.018

3.  Changes in substance P levels of inferior turbinate in patients with mucosal contact headache.

Authors:  Hülya Eyigör; Mete Eyigör; Bekir Erol; Ömer Tarık Selçuk; Levent Renda; Mustafa Deniz Yılmaz; Üstün Osma; Cansu Demirkıran; Meral Gültekin; Nuray Erin
Journal:  Braz J Otorhinolaryngol       Date:  2019-02-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.